Inside the James P. Allison Institute
About the James P. Allison Institute
Leadership
Director
Dr. Allison was awarded the 2018 Nobel Prize in Physiology or Medicine jointly with Tasuku Honjo, M.D., Ph.D., for discoveries that launched the field of cancer immunotherapy. Allison's fundamental research provided new insights into T cell biology and led to his invention of ipilimumab. He is vice president of Immunobiology and chair of Immunology at MD Anderson, and he was named a regental professor by The University of Texas System Board of Regents. He holds the Olga Keith Wiess Distinguished University Chair for Cancer Research and also is executive director of MD Anderson's immunotherapy platform.
Director of Scientific Programs
Dr. Sharma is a renowned physician scientist who is a pioneer of immune checkpoint therapy, leading some of the earliest clinical trials in the field. She is associate vice president of Immunobiology and professor of Genitourinary Medical Oncology with a dual appointment as professor of Immunology at MD Anderson. She holds the T.C. and Jeanette D. Hsu Endowed Chair in Cell Biology and is scientific director of MD Anderson's immunotherapy platform.
Meet our researchers, collaborators and advisors
TMC Helix Park
Housed in the TMC3 Collaborative Building at Helix Park, the Allison Institute is an anchor of MD Anderson’s growing south campus research environment. TMC3 is a destination for influential lectures, illumination conversations, game-changing collaborations and big ideas to stimulate progress across science and medicine.
Helix Park Campus